Latest News in the pharma Industry

All

First ever biosimilar of interferon beta-1a approved in Russia

First ever biosimilar of interferon beta-1a approved in Russia

5 Mar 2017

Represents Biocad's third authorized medicine for the treatment of relapsing-remitting multiple sclerosis.

Read more 
CDMO invests in system to boost pharmaceutical formulation development

CDMO invests in system to boost pharmaceutical formulation development

5 Mar 2017

Alcami will use the D8 DISCOVER HTS to add XRD capabilities to their laboratory service portfolio.

Read more 
Allergopharma opens new biopharmaceutical production in Reinbek

Allergopharma opens new biopharmaceutical production in Reinbek

4 Mar 2017

Merck's €42 million investment expands the allergies business on a global scale.

Read more 
Sanofi Pasteur and MedImmune collaborate on monoclonal antibody to prevent illnesses associated with RSV

Sanofi Pasteur and MedImmune collaborate on monoclonal antibody to prevent illnesses associated with RSV

4 Mar 2017

MEDI8897 has been engineered to have a long half-life so that only one dose would be needed for the entire RSV season.

Read more 
Contract manufacturer Pfizer CentreOne expands fill-finish services to its Kalamazoo, Michigan, facility

Contract manufacturer Pfizer CentreOne expands fill-finish services to its Kalamazoo, Michigan, facility

2 Mar 2017

Site provides vial-filling of small and large molecules plus sterile suspensions

Read more 
NICE expands positive recommendation for Erbitux as first-line treatment for RAS wild-type mCRC

NICE expands positive recommendation for Erbitux as first-line treatment for RAS wild-type mCRC

2 Mar 2017

More patients now able to receive a standard-of-care treatment with Erbitux plus Folfiri or Folfox.

Read more 
Roquette commits to bioharma market with new products

Roquette commits to bioharma market with new products

2 Mar 2017

Reinforces position as a supplier of excipients and raw materials for the pharmaceutical and biopharmaceutical industries.

Read more 
Arquer Diagnostics awarded funding under Innovate UK’s Biocatalyst programme

Arquer Diagnostics awarded funding under Innovate UK’s Biocatalyst programme

2 Mar 2017

Funding will be used to prepare for international clinical study to evaluate the Company’s ELISA-based urine test for prostate cancer.

Read more 
Astellas and Affinivax announce worldwide partnership for MAPS vaccine targeting pneumococcal disease

Astellas and Affinivax announce worldwide partnership for MAPS vaccine targeting pneumococcal disease

2 Mar 2017

Affinivax’s MAPS vaccine technology overcomes the limitations of current conjugate vaccine technology, creating a MAPS pneumococcal vaccine that enables broader protection.

Read more 
Russia’s pharmaceutical market to double to $39 billion by 2021

Russia’s pharmaceutical market to double to $39 billion by 2021

1 Mar 2017

Government plans to construct 10 factories for the manufacturing of biosimilars by 2020, with an additional investment of $265.3 million.

Read more 
CPhI expands in Middle East & Africa with Abu Dhabi event in 2018

CPhI expands in Middle East & Africa with Abu Dhabi event in 2018

1 Mar 2017

CPhI Middle East & Africa is a natural progression and rebrand of the rapid growth seen at CPhI Istanbul.

Read more 
Lilly completes acquisition of CoLucid Pharmaceuticals

Lilly completes acquisition of CoLucid Pharmaceuticals

1 Mar 2017

Acquisition enhances Lilly's existing pain management.

Read more